Docs: Don't end CME support

A poll of 268 physicians found that 92% disagree with an American Medical Association (AMA) committee's call to end commercial support of CME.

Respondents to the online poll, by Pri-Med, expressed concern that a ban on commercial support would make it more expensive to receive CME and that the quality would decrease, making it harder for doctors to stay current and ultimately impacting patient care.

“I don't receive CME reimbursement from my employer,” said one respondent. “Any subsidy is very beneficial to me.” The call to end CME was rebutted at the AMA House of Delegates meeting last month.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.